Based on listening and talking with a diverse range of industry colleagues, attending several conferences, reading the FDA mAb announcement and roadmap, watching the FDA/NIH workshop on the state of phasing out the use of animal testing, and the FDA’s engagement with 3Rs, the world of in vitro toxicology has been speeding up faster than I've seen before, and it is clear New Approach Methods (NAMs) are playing a more central role in predictive toxicology. Here is some evidenc

The final day of WC13 may have been a half day, but it ended on a powerful note. The closing keynote speaker, Dr. Nicole Kleinstreuer,...

The 13th World Congress on Alternatives and the Use of Animals in the Life Sciences (WC13) is in full swing in Rio de Janeiro. Over the...

Reflections from the Opening Ceremony of WC13 in Rio de Janeiro The 13th World Congress on Alternatives and the Use of Animals in the...

The 13th World Congress on Alternatives and the Use of Animals in the Life Sciences (WC13) is fast approaching, taking place in Rio de...

The 13th World Congress (WC13) on Alternatives to Animal Use in Life Sciences is coming up soon, taking place August 31 – September 4,...

Traditional  in vitro  system s  and animal models often fail to replicate the complexity of the human respiratory system accurately. As...

I had the privilege of co-authoring a paper titled “Panel discussions on the global regulatory acceptance and harmonization of non-animal...

I was honoured to be invited to the Animal Free Safety Assessment Collaboration (AFSA) Collaboration retreat last week. The objective of...

On April 10, 2025, the FDA announced a phased plan to reduce and eventually replace animal testing within the drug development process...

Roper Toxicology Consulting Limited (RTCL) continues to support environmental sustainability by signing the Midlothian Business Green...

We are excited to announce that the UK Government Small Business Commissioner has awarded Roper Toxicology Consulting Limited the Gold...

The Society of Toxicology (SOT) Annual Meeting is almost here, and we are excited to be part of this prestigious event. This year, I'll...

On 02 March 2021, Roper Toxicology Consulting Limited was founded initially to support two clients with urgent in vitro  toxicology...

I have joined the Animal-Free Safety Assessment (AFSA) Collaboration ( https://www.afsacollaboration.org ) Global Science Committee. The...

For the third year in a row, Roper Toxicology Consulting Limited is proud to sponsor #TreeTimeEdinburgh , part of the Edinburgh &...

Publishing in peer-reviewed journals is always challenging, especially within the toxicology industry, where legal and commercial...

I'm excited to share our latest work, “The Use of MPS in Three Rs and Regulatory Applications: Perspectives from Developers on...

There is nothing quite like kicking off the year (and promoting a fresh, exciting journal) with a thought -provoking Editorial piece. Of...

The #Kenvue and #RoperTCL webinar hosted by the Dermal Toxicology Specialty Section (#DTSS) of The Society of Toxicology (#SOT) has now...